ARCHIVES

NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War

This article is from The Cancer Letter archive.

Vol. 12 No. 38 | October 3, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Trials Approved by NCI CTEP Last Month

November 25, 2011

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

DCE Advisors Approve New Grant Program On Lung Carcinoma

June 30, 1995

June Panel Meeting Dropped

June 3, 1977

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005